Cumberland Pharmaceuticals Inc. (CPIX) will visit the NASDAQ
MarketSite in New York City's Times Square to celebrate the company's recent IPO. Cumberland priced its IPO on August 10, 2009, representing the first biopharmaceutical IPO in the U.S. in nearly two years. The company has also recently launched its new Caldolor product, which was approved by the FDA in June 2009 and is an injectable formulation of ibuprofen for treatment of pain and fever.
In honor of the occasion, A.J. Kazimi, Chief Executive Officer of
Cumberland Pharmaceuticals Inc. (CPIX), and Cumberland representatives will ring The NASDAQ Stock Market Closing Bell.
Live broadcast of event available from 3:50 PM ET to 4:05 PM ET
Please sign up for